Robert Olstein's JNJ Position Overview
Robert Olstein (via Olstein Capital Management, L.P.) currently holds 48,500 shares of Johnson & Johnson (JNJ) worth $8.99 M, representing 1.70% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 50 quarters.
Based on 13F filings since 2013, Robert Olstein has maintained a long-term strategic position in JNJ, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2014, adding 19,000 shares. Largest reduction occurred in Q2 2014, reducing 23,000 shares.
Analysis based on 13F filings available since 2013 Q2
Robert Olstein's Johnson & Johnson (JNJ) Holding Value Over Time
Track share changes against reported price movement
Quarterly Johnson & Johnson (JNJ) Trades by Robert Olstein
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +90,001 | Add 0.00% | 90,000 | $85.86 |
| Q3 2013 | +2,000 | Add 2.22% | 92,000 | $86.68 |
| Q4 2013 | -1,000 | Reduce 1.09% | 91,000 | $91.59 |
| Q1 2014 | +19,000 | Add 20.88% | 110,000 | $98.23 |
| Q2 2014 | -23,000 | Reduce 20.91% | 87,000 | $104.62 |
| Q3 2014 | -4,000 | Reduce 4.60% | 83,000 | $106.59 |
| Q4 2014 | -12,000 | Reduce 14.46% | 71,000 | $104.56 |
| Q1 2016 | -21,000 | Reduce 29.58% | 50,000 | $108.20 |
| Q2 2016 | -9,000 | Reduce 18.00% | 41,000 | $121.29 |
| Q3 2016 | -11,000 | Reduce 26.83% | 30,000 | $118.13 |
| Q4 2016 | -1,000 | Reduce 3.33% | 29,000 | $115.21 |
| Q2 2017 | -29,000 | Sold Out | 29,000 | $0.00 |
| Q2 2020 | +26,000 | New Buy | 26,000 | $140.62 |
| Q3 2020 | +8,000 | Add 30.77% | 34,000 | $148.88 |
| Q4 2020 | +11,000 | Add 32.35% | 45,000 | $157.38 |
| Q1 2021 | +19,000 | Add 42.22% | 64,000 | $164.34 |
| Q4 2021 | +7,000 | Add 10.94% | 71,000 | $171.07 |
| Q2 2022 | -10,000 | Reduce 14.08% | 61,000 | $177.51 |
| Q3 2022 | -3,000 | Reduce 4.92% | 58,000 | $163.36 |
| Q4 2022 | -10,000 | Reduce 17.24% | 48,000 | $176.65 |
| Q1 2023 | +12,000 | Add 25.00% | 60,000 | $155.00 |
| Q2 2024 | +1,000 | Add 1.67% | 61,000 | $146.16 |
| Q4 2024 | +4,000 | Add 6.56% | 65,000 | $144.62 |
| Q1 2025 | -4,000 | Reduce 6.15% | 61,000 | $165.84 |
| Q3 2025 | -12,500 | Reduce 20.49% | 48,500 | $185.42 |
Robert Olstein's Johnson & Johnson Investment FAQs
Robert Olstein first purchased Johnson & Johnson (JNJ) in Q2 2013, acquiring 90,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Robert Olstein has held Johnson & Johnson (JNJ) for 50 quarters since Q2 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Robert Olstein's largest addition to Johnson & Johnson (JNJ) was in Q2 2013, adding 90,000 shares worth $7.73 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Robert Olstein's firm, Olstein Capital Management, L.P., owns 48,500 shares of Johnson & Johnson (JNJ), valued at approximately $8.99 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Johnson & Johnson (JNJ) represents approximately 1.70% of Robert Olstein's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Robert Olstein's peak holding in Johnson & Johnson (JNJ) was 110,000 shares, as reported at the end of Q1 2014. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.